Evidence map›Paper›PMID 20462271›Full record

ArticleJournal of natural products2010

Cryptosphaerolide, a cytotoxic Mcl-1 inhibitor from a marine-derived ascomycete related to the genus Cryptosphaeria.

Hyuncheol Oh, Paul R Jensen, Brian T Murphy, Catherine Fiorilla, John F Sullivan, Timothy Ramsey, William Fenical

Abstract read
In one paragraph

Article in Journal of natural products, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Targeting MCL-1 in cancer: current status and perspectives.Journal of hematology & oncology · 2021
    Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hyuncheol OhCenter for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California-San Diego, La Jolla, California 92093-0204, USA.
Paul R Jensen
Brian T Murphy
Catherine Fiorilla
John F Sullivan
Timothy Ramsey
William Fenical

Funding

Targeted Discovery of Marine-derived Anticancer LeadsU19CA052955 · NCI · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI CREWS, PHIL · 1995 to 2009
$9.7M
NCI NIH HHS 5U19CA52955NCI NIH HHS U19 CA052955
6 · The paper itself

Abstract

Examination of the saline fermentation products from the marine-derived ascomycete fungal strain CNL-523 (Cryptosphaeria sp.) resulted in the isolation of cryptosphaerolide (1). The new compound is an ester-substituted sesquiterpenoid related to the eremophilane class. The structure of the new compound was assigned by spectroscopic and chemical methods. Cryptosphaerolide was found to be an inhibitor of the protein Mcl-1, a cancer drug target involved in apoptosis. It also showed significant cytotoxicity against an HCT-116 human colon carcinoma cell line, indicating that the compound may be of value in exploring the Mcl-1 pathway as a target for cancer chemotherapy.

Indexed as

Amino Acid SequenceAntineoplastic AgentsApoptosisAscomycotaBahamasDrug Screening Assays, AntitumorHCT116 CellsHumansMarine BiologyMolecular StructureMyeloid Cell Leukemia Sequence 1 ProteinNuclear Magnetic Resonance, BiomolecularProto-Oncogene Proteins c-bcl-2SesquiterpenesAntineoplastic AgentscryptosphaerolideMyeloid Cell Leukemia Sequence 1 ProteinProto-Oncogene Proteins c-bcl-2Sesquiterpenes

Identifiers

PMID20462271
PMCPMC2901504

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.